EOS Imaging (Formerly Known as biospace med) Release: New Studies Highlight Benefits of EOS ®3D Imaging in Assessing Corrective Bracing for Scoliosis

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--EOS imaging (NYSE Euronext, FR0011191766-EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced that two new studies supporting the use of its 3D imaging technology in assessing the impact of bracing for adolescent idiopathic scoliosis (AIS) have been published online in the European Spine Journal. Bracing is the preferred therapy for progressive scoliosis with a Cobb angle (curve) in the range of 20° to 45°, though current data on its efficacy in correcting spinal curvatures are inconclusive.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC